These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2321057)

  • 21. Testing for anti-p53 antibodies increases the diagnostic sensitivity of conventional tumor markers.
    Müller M; Meyer M; Schilling T; Ulsperger E; Lehnert T; Zentgraf H; Stremmel W; Volkmann M; Galle PR
    Int J Oncol; 2006 Oct; 29(4):973-80. PubMed ID: 16964393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarkers for cancer risk, early detection, and prognosis: the validation conundrum.
    Brenner DE; Normolle DP
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1918-20. PubMed ID: 17932336
    [No Abstract]   [Full Text] [Related]  

  • 23. [Serodiagnosis: tumor marker].
    Yoneshima M; Hattori N; Sawabu N
    Gan No Rinsho; 1988 Aug; 34(10):1209-15. PubMed ID: 2459425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards evidence-based use of serum tumour marker requests: an audit of use in a tertiary hospital.
    Colls BM
    Intern Med J; 2005 Oct; 35(10):640. PubMed ID: 16207271
    [No Abstract]   [Full Text] [Related]  

  • 25. [The clinico-diagnostic significance of tumor markers in malignant neoplasms].
    Seliuzhitskiĭ IV; Skvortsov SV; Lytsar' BN
    Voen Med Zh; 1993 Mar; (3):27-8. PubMed ID: 8498043
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum haptoglobin type and cancer.
    Larkin MF
    J Natl Cancer Inst; 1967 Oct; 39(4):633-8. PubMed ID: 18623925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrochemical and chemiluminescent immunosensors for tumor markers.
    Lin J; Ju H
    Biosens Bioelectron; 2005 Feb; 20(8):1461-70. PubMed ID: 15626599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tumor markers--how they should be applied].
    Stieber P; Heinemann V; Schalhorn A
    MMW Fortschr Med; 2005 May; 147(20):35, 37-9. PubMed ID: 15957858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Application of multifactorial statistical calculation in research for a correlation between lipid soluble vitamins and cancer].
    Rougereau A
    Ann Gastroenterol Hepatol (Paris); 1993; 29(1):46-52. PubMed ID: 8382901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New immunoassay for oncology. Cancer test in a combination pack? Interview by Dipl.-Bioch. Petra Eiden].
    Schmolke B
    MMW Fortschr Med; 2000 Dec; 142(49-50):12. PubMed ID: 11190934
    [No Abstract]   [Full Text] [Related]  

  • 31. High D-dimer level at presentation in patients with venous thrombosis is a marker for malignancy.
    Paneesha S; Cheyne E; French K; Delgado J; Borg A; Rose P
    Haematologica; 2005 Dec; 90(12 Suppl):ELT08. PubMed ID: 16464765
    [No Abstract]   [Full Text] [Related]  

  • 32. Detection of cancer by tumor markers in the blood: a view to the future.
    Sell S
    Crit Rev Oncog; 1993; 4(4):419-33. PubMed ID: 8353141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum tumour markers: how to order and interpret them.
    Sturgeon CM; Lai LC; Duffy MJ
    BMJ; 2009 Sep; 339():b3527. PubMed ID: 19773328
    [No Abstract]   [Full Text] [Related]  

  • 34. Renal function and serum concentration of five tumor markers (TATI, SCC, CYFRA 21-1, TPA, and TPS) in patients without evidence of neoplasia.
    Tramonti G; Ferdeghini M; Donadio C; Norpoth M; Annichiarico C; Bianchi R; Bianchi C
    Cancer Detect Prev; 2000; 24(1):86-90. PubMed ID: 10757127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple biomarkers in molecular oncology.
    Johann DJ; Veenstra TD
    Expert Rev Mol Diagn; 2007 May; 7(3):223-5. PubMed ID: 17489728
    [No Abstract]   [Full Text] [Related]  

  • 36. [Further study of tumor markers].
    Li C
    Zhonghua Yi Xue Za Zhi; 1993 Aug; 73(8):451-2. PubMed ID: 7509251
    [No Abstract]   [Full Text] [Related]  

  • 37. [Circulating tumor markers].
    Pichon MF; Pecking A
    Pathol Biol (Paris); 1993 Jan; 41(1):35-6. PubMed ID: 8316461
    [No Abstract]   [Full Text] [Related]  

  • 38. [A gene probe test for serum RNA proteolipid in neoplasia].
    Wieczorek AJ; Rhyner K
    Schweiz Med Wochenschr; 1989 Sep; 119(39):1342-3. PubMed ID: 2477896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [How reliable are tumor markers? Only the experienced physician knows how to apply these diagnostic aids sensibly].
    Janssen K
    Fortschr Med; 1995 Feb; 113(4):49-51. PubMed ID: 7713468
    [No Abstract]   [Full Text] [Related]  

  • 40. CA-50 and CA-19.9 as tumour markers: which is preferable?
    Maréchal F; Berthiot G; Legrand MG; Larbre H; Cattan A; Deltour G
    Anticancer Res; 1990; 10(4):977-82. PubMed ID: 2382997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.